You can now follow the latest news for free through the Telegram app
Click here to subscribe
—
A British scientist who is co-leading the efforts to develop a vaccine for Covid-19 confirmed that the vaccine that the world is waiting for if it proves successful will be priced so that it can be obtained as widely as possible, and it will be manufactured on a large scale to reduce costs and increase supply.
Elaph: Adrian Hill, director of the Jenner Institute at Oxford University, who is collaborating with AstraZeneca drug maker to develop the vaccine, explained that ensuring the vaccine’s wide distribution and lowering costs was essential to the project from the start.
In an interview with Reuters, he said: “This vaccine will not be too expensive. It will be a vaccine given in one dose. It will be manufactured to provide it globally … in many different locations. This has always been our plan.”
Hill and his team are competing in a frantic race to reach a vaccine to prevent the emerging corona virus, which caused the Covid-19 disease pandemic.
Initial data from an experimental vaccine trial on six monkeys showed that some developed antibodies against the virus within 14 days after being given a single dose, while all developed protective antibodies within 28 days.
When the monkeys were exposed to the Coruna virus, the vaccine seemed to prevent damage to the lungs, and prevent the virus from cloning, even though it was still actively reproducing in the nose.
It should be noted that the Hill team started early human vaccine trials in April, making it one of the few research teams that have reached this stage.
Topics that may interest you:
– .
